Cancer survivorship care plan
Adjuvant hormone therapy occurs at the end of a very supervised and reassuring hospital care, which leaves some patients with a feeling of being abandoned [SCP includes, at the medical level, a consultation with the oncologist and the breast nurse about 15 days after the end of radiotherapy, during which hormone therapy is prescribed and potential side effects induced by treatments are discussed. Patients are then seen 6 and 18 months after the start of hormone therapy. In case of medical issue, patients should be referred to their attending physician, who is involved from the beginning of the treatment. Information is systematically shared between general practitioners and specialists in order to optimize the quality of follow-up. Concurrently, a team of breast nurses is available to provide personalized follow-up throughout the treatment process, by listening, assessing the patient’s needs, informing, advising and offering continuous emotional and social support.